miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A

INTRODUCTION: Triple-negative breast cancer (TNBC) is the most aggressive malignancy of breast cancer, which represents about 20% of all cases. The prognosis of TNBC remains unfavorable due to the lack of targeted therapy and chemoresistance. The aim of this study is to investigate the role of miR-6...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cuiping, Jiang, Yizhou, Han, Baosan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733386/
https://www.ncbi.nlm.nih.gov/pubmed/33324107
http://dx.doi.org/10.2147/CMAR.S276316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733386/
https://www.ncbi.nlm.nih.gov/pubmed/33324107
http://dx.doi.org/10.2147/CMAR.S276316

Ejemplares similares